Bipolar Depression Market Analysis, Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight
(Albany, NY) DelveInsight has launched a new report on “Bipolar Depression Market Insight, Epidemiology and Market Forecast -2030.”
DelveInsight's "Bipolar
Depression Market Insights and Forecast Report" delivers an
in-depth understanding of the Bipolar Depression, historical and forecasted
epidemiology as well as the Bipolar Depression market trends, pipeline
scenario, Bipolar Depression market drivers, barriers, and forecasted analysis
in the 7MM for the study period 2017-30.
- · As per DelveInsight analysts, the total diagnosed prevalent population of Bipolar Depression in the 7MM was 1,857,545 in 2017.
- · The estimates show the highest diagnosed prevalence of Bipolar Depression in the United States with 740,715 cases in 2017.
- · Bipolar I and Bipolar II are the major subtypes of BD.
- · In 2017, out of the total diagnosed prevalent population of 740,715 cases in the US for Bipolar Depression, 291,134 and 449,581 cases were contributed by Bipolar I disorder and Bipolar II disorder, respectively.
- The
Bipolar Depression report covers the descriptive overview of Bipolar
Depression, explaining its causes, signs and symptoms, pathophysiology,
diagnosis and currently available therapies
- Comprehensive
insight has been provided into the Bipolar Depression epidemiology and treatment
in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Bipolar Depression are provided, along with the assessment of new
therapies, which will have an impact on the current treatment landscape
- A
detailed review of Bipolar Depression market; historical and forecasted is
included in the report, covering drug outreach in the 7MM
- The
Bipolar Depression report provides an edge while developing business
strategies, by understanding trends shaping and driving the global Bipolar
Depression market
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market
Bipolar
Depression (Manic depression) is categorized by
recurrent-shifts in the mood/temper and is a manic-depressive disorder
hindering the routine life of an individual.
The American Psychiatric Association categorizes Bipolar
Depression into four major types of Bipolar Depression: Bipolar I disorder,
Bipolar II disorder, Cyclothymic disorder, and Bipolar Depression due to
another medical or substance abuse disorder.
Bipolar Depression
affects about 45 million people worldwide, says WHO.
Bipolar
Depression Market: Marketed, and Upcoming Drugs
FDA-approved agents for the acute treatment of bipolar
depression include Olanzapine-fluoxetine combination, Lurasidone, and
Quetiapine.
Other off-label therapies present in the Bipolar Depression
market are Anticonvulsants (such as Divalproex and
lamotrigine), olanzapine monotherapy, and Lithium and
lamotrigine combined therapy.
The Bipolar Depression market report covers detailed picture
of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. The
report helps in providing a better understanding of clinical trial details,
expressive pharmacological action, agreements and collaborations, approval and
patent details, advantages and disadvantages of each included drug and the
latest news and press releases.
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market
·
Vraylar (Cariprazine)
·
Latuda (Lurasidone Hydrochloride)
·
Abilify (Aripiprazole)
·
Lumateperone/ITI-007
·
NRX-100/NRX-101
·
Psilocybin
·
Zuranolone (SAGE-217)
·
SEP-4199
·
ILT101
·
Falkieri (Esketamine DPI)
·
And Many Others
Some
of the Key Companies Covered:
·
Allergan (AbbVie)/Gedeon Richter
·
Sunovion Pharmaceuticals (Sumitomo Dainippon
Pharma)
·
Otsuka Pharmaceutical
·
Intra-cellular Therapies
·
NeuroRx
·
COMPASS Pathways
·
Sage Therapeutics
·
Sunovion/Sumitomo Dainippon Pharma
·
Iltoo Pharma
·
Celon Pharma
·
And Many Others
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market
Bipolar
Depression Report Highlights
- Dynamic
Bipolar Depression market trends
- Healthcare
spending fuelling Bipolar Depression Market
- Collaborations,
mergers, and acquisitions in Market
- Challenges
poised and opportunities present influencing Bipolar Depression Market
- R&D
driving Market
- Novel
therapies and drugs in Bipolar Depression pipeline
- Major
players involved impacting Bipolar Depression market
- In-depth
analysis of the pipeline products (Phase III and Phase II), comparative
analysis with detailed clinical profiles, key cross-competition, launch
date along with product development activities
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market
Table of Contents
1. Key Insights
2. Executive Summary of Bipolar Depression
3. Competitive Intelligence Analysis for Bipolar Depression
4. Bipolar Depression: Market Overview at a Glance
5. Bipolar Depression: Disease Background and Overview
6. Patient Journey
7. Bipolar Depression Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical
Practices
9. Unmet Needs
10. Key Endpoints of Bipolar Depression Treatment
11. Marketed Products
12. Emerging Therapies
13. Bipolar Depression: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Bipolar Depression
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Request for Detailed TOC: https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market
About DelveInsight
DelveInsight is a premier Business Consulting and Market
Research firm focused exclusively on the life science segment. With a wide
array of smart end-to-end solutions, the firm helps the global Pharmaceutical
and Bio-Tech companies formulate prudent business decisions for
Browse through our vast repository from here.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Bipolar Depression market,Bipolar Depression market
research,Bipolar Depression market insight,Bipolar Depression market trends,Bipolar
Depression market forecast,Bipolar Depression market share,Bipolar Depression
pipeline drugs,Bipolar Depression treatment algorithm,Bipolar Depression
drugs,Bipolar Depression sales forecasting,Bipolar Depression market
size,Bipolar Depression disease,Bipolar Depression epidemiology,Bipolar
Depression
Comments
Post a Comment